Search results for "Risk score"

showing 8 items of 168 documents

The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control an…

2019

Background: Some recent studies have challenged the direction of causality for the association between cannabis use and psychotic disorder, suggesting that cannabis use initiation is explained by common genetic variants associated with risk of schizophrenia. We used data from the European Union Gene-Environment Interaction consortium (EUGEI) case-control study to test for the independent and combined effect of heavy cannabis use, and of Schizophrenia Polygenic risk score (SZ PRS), on risk for psychotic disorder. Methods: Genome-wide data were obtained from 492 first episode psychosis patients (FEPp) and from 787 controls of European Ancestry, and used to generate SZ PRS from the summary res…

medicine.medical_specialtybiologybusiness.industryFrequency of useCannabis usebiology.organism_classificationmedicine.disease030227 psychiatry3. Good health03 medical and health sciences0302 clinical medicineSchizophreniaFirst episode psychosisCase control analysisMedicinemedia_common.cataloged_instancePolygenic risk scoreCannabisEuropean unionbusinessPsychiatry030217 neurology & neurosurgerymedia_common
researchProduct

2019

Cardiovascular disease (CVD) is the leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD). The current analysis expands the knowledge on atherogenic lipid profiles in NAFLD by modeling changes in low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in a prospectively enrolling real-life study cohort to inform physicians on the cardiovascular (CV) event risk based on these changes. A total of 304 patients with histologically confirmed NAFLD were included (mean age, 52 years; equal sex distribution). Of these, 129 (42.4%) patients exhibited a NAFLD activity score ≥4 and 186 (61.2%) had at least intermediate fibrosis ≥F2. The median TC levels were 2…

medicine.medical_specialtyeducation.field_of_studyFramingham Risk ScoreHepatologybusiness.industryPopulationmedicine.diseaseGastroenterologyFibrosisInterquartile rangeInternal medicineCohortNonalcoholic fatty liver diseasemedicinelipids (amino acids peptides and proteins)In patienteducationbusinessCause of deathHepatology Communications
researchProduct

Tailoring anticoagulant treatment of patients with atrial fibrillation using a novel bleeding risk score

2021

ObjectivesCurrent international guidelines advocate the application of bleeding risk scores only to identify modifiable risk factors, but not to withhold treatment in patients at high risk of bleeding. VTE-BLEED (ActiVe cancer, male with uncontrolled hyperTension, anaEmia, history of BLeeding, agE and rEnal Dysfunction) is a simple bleeding risk score that predicts major bleeding (MB) in patients with venous thromboembolism, but has never been evaluated in patients with atrial fibrillation (AF). We sought to evaluate VTE-BLEED in patients with AF included in the Randomised Evaluation of Long-term anticoagulant therapY (RE-LY) trial, to assess whether score classes (high vs low bleeding risk…

medicine.medical_specialtyeducation.field_of_studyFramingham Risk Scorebusiness.industry10031 Clinic for AngiologyIncidence (epidemiology)PopulationCancer610 Medicine & healthAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseDabigatran03 medical and health sciences0302 clinical medicineInternal medicineRelative riskMedicineatrial fibrillation030212 general & internal medicineCardiology and Cardiovascular MedicinebusinesseducationStrokemedicine.drug
researchProduct

New Risk Score for Patients With Acute Chest Pain, Non-ST-Segment Deviation, and Normal Troponin Concentrations

2005

Objectives The purpose of this research was to develop a risk score for patients with chest pain, non-ST-segment deviation electrocardiogram (ECG), and normal troponin levels. Background Prognosis assessment in this population remains a challenge. Methods A total of 646 consecutive patients were evaluated by clinical history (risk factors and chest pain score according to pain characteristics), ECG, and early exercise testing. ST-segment deviation and troponin elevation were exclusion criteria. The primary end point was mortality or myocardial infarction at one year. The secondary end point was mortality, myocardial infarction, or urgent revascularization at 14 days (similar to the Thrombol…

medicine.medical_specialtyeducation.field_of_studyFramingham Risk Scorebusiness.industryPopulationmedicine.diseaseChest painAnginaInternal medicinemedicineCardiologyMyocardial infarctionMyocardial infarction diagnosisRisk factormedicine.symptombusinesseducationCardiology and Cardiovascular MedicineTIMIJournal of the American College of Cardiology
researchProduct

Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System

2021

Abstract Objectives The purpose of this observational first-in-human experience was to investigate the feasibility and safety of the EVOQUE tricuspid valve replacement system and its impact on short-term clinical outcomes. Background Transcatheter tricuspid intervention is a promising option for selected patients with severe tricuspid regurgitation (TR). Although transcatheter leaflet repair is an option for some, transcatheter tricuspid valve replacement (TTVR) may be applicable to a broader population. Methods Twenty-five patients with severe TR underwent EVOQUE TTVR in a compassionate-use experience. The primary outcome was technical success, with NYHA (NYHA) functional class, TR grade, …

medicine.medical_specialtyeducation.field_of_studyFramingham Risk Scorebusiness.industrymedicine.medical_treatmentPopulationTricuspid valve replacement030204 cardiovascular system & hematologySystem aSurgery03 medical and health sciences0302 clinical medicinecardiovascular systemEtiologyMedicineObservational studycardiovascular diseases030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessProspective cohort studyeducationDialysisJACC: Cardiovascular Interventions
researchProduct

Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.

2021

Background Routine manual thrombectomy (MT) is not recommended in primary percutaneous coronary intervention (P-PCI) but it is performed in many procedures. The objective of our study was validating the DDTA score, designed for selecting patients who benefit most from MT. Methods Observational and multicenter study of all consecutive patients undergoing P-PCI in five institutions. Results were compared with the design cohort and the performance of the DDTA was analyzed in all patients. Primary end-point of the analyses was TIMI 3 after MT; secondary endpoints were final TIMI 3, no-reflow incidence, in-hospital mortality and in-hospital major cardiovascular events (MACE). In-hospital prognos…

medicine.medical_specialtymedicine.medical_treatmentMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionInternal medicineMedicineHumansRadiology Nuclear Medicine and imagingIn patient030212 general & internal medicinecardiovascular diseasesEdetic AcidThrombectomyPrimary angioplastyFramingham Risk Scorebusiness.industryIncidence (epidemiology)Percutaneous coronary interventionGeneral MedicineTreatment OutcomeMulticenter studyCohortCardiology and Cardiovascular MedicinebusinessTIMIMace
researchProduct

Heart rate and other risk factors in outpatients with stable coronary artery disease in Latvia

2011

Heart rate and other risk factors in outpatients with stable coronary artery disease in Latvia The aim of the study was to characterise coronary artery disease (CAD) outpatients in Latvia by risk factors (RF) including heart rate (HR), physical examination data, clinical data and treatment. Twelve practitioners had each examined and questioned 6 to 12 patients with established CAD (n = 120). The most frequent cardiovascular (CV) RF and co-morbidity were dyslipidemia (94.2%) and hypertension (78.3%), respectively. Prevalence of increased resting HR (≥70 bpm) was 35.9% and 33.6%, when measured by pulse palpation and electrocardiography, respectively. Regarding other RFs, prevalence of treated…

resting heart ratemedicine.medical_specialtyMultidisciplinaryFramingham Risk ScoreGeneral interestScienceQmedicine.diseaseRESTING HEART RATECoronary artery diseaseInternal medicineHeart rateoutpatientmedicineCardiologyrisk factorscoronary artery diseaseProceedings of the Latvian Academy of Sciences. Section B, Natural Sciences
researchProduct

The challenges of GxE research: A rejoinder

2017

ta511genetiikka030505 public healthHealth (social science)ympäristötekijätta1184genetic risk scoresbiomarkersta3142riskitekijätgene-environment interactionsHealth outcomes01 natural sciencesData science010104 statistics & probability03 medical and health sciencesHistory and Philosophy of Sciencemarkkeritidentificationhealth outcomesIdentification (biology)terveyserot0101 mathematics0305 other medical sciencePsychologySocial Science & Medicine
researchProduct